The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Q3 2025 Earnings Call Feb 18, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 2:15 p.m. PST (4:15 p.m. CST). Immediately following ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...

Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance.